Status:
RECRUITING
Effect GnRH Agonist Administration in Endometriosis Cyst Patients
Lead Sponsor:
Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
Collaborating Sponsors:
Dexa Medica Group
Conditions:
Endometriosis
Eligibility:
FEMALE
18-40 years
Phase:
PHASE3
Brief Summary
Endometriosis is a chronic disease that affects 10-15% of women of childbearing age. The most common symptom is pelvic pain. One of the treatment options that has been proven effective in treating end...
Detailed Description
There will be 2 groups of treatment; each group will consist of 16 subjects with study period for 18 weeks. Treatment I : twice before surgery (baseline and week-6) and once after surgery at week-12 ...
Eligibility Criteria
Inclusion
- Female subjects aged 18 to 40 years.
- The subjects was diagnosed with endometriosis cysts.
- Willing to participate in research and sign informed consent before all research-related activities begin.
- Regular menstruation (within 25 - 35 day intervals) in the last 3 months before the study was conducted.
Exclusion
- The patient used hormonal contraception in the last 3 months prior to the study.
- Using a GnRH agonist within the past 3 months.
- Using the hormone progesterone within the last 3 months
- Pregnancy, breastfeeding females
- History of osteoporosis
- History of blood clotting disorders
- History of heart and blood vessel disorders
Key Trial Info
Start Date :
January 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2025
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT06525155
Start Date
January 2 2024
End Date
February 1 2025
Last Update
November 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Obstetrics and Gynecology Central Army Hospital Gatot Soebroto
Jakarta, Indonesia, 10410